Table 1.

Clinical characteristics of all patients with validated primary mucinous ovarian cancer

Characteristics (n=163)	All ethnicities, N (%)/median (IQR)	South Asian (n=19)	White (n=119)
Stage at diagnosis
1A	76 (47%)	5 (26%)	58 (49%)
1B	1 (1%)	0 (0%)	1 (1%)
1C	68 (42%)	13 (68%)	45 (38%)
2	4 (2%)	0 (0%)	3 (3%)
3	14 (9%)	1 (5%)	12 (10%)
Invasion type
Infiltrative	43 (26%)	6 (32%)	28 (24%)
Expansile	101 (62%)	12 (63%)	77 (64%)
Not available	19 (12%)	1 (5%)	14 (12%)
Surgeon
Gynecological oncologist	116 (71%)	8 (42%)	93 (78%)
Gynecologist	46 (28%)	10 (53%)	26 (22%)
No surgical attempt	1 (1%)	1 (5%)	0 (0%)
Surgery type
Fertility-sparing surgery	19 (12%)	6 (32%)	10 (8%)
Traditional staging surgery	139 (85%)	12 (63%)	106 (89%)
No surgical treatment	5 (3%)	1 (5%)	3 (3%)
Adjuvant chemotherapy
Yes	66 (40%)	11 (58%)	49 (41%)
No	97 (60%)	8 (42%)	70 (59%)
Survival
5-Year overall survival	136 (79%)	13 (59%)	101 (83%)
Median survival (IQR)	75 (31, 132)	46 (17, 72)	89 (35,138)